ASSESSMENT OF HEMATOLOGIC INDICES AND THEIR CORRELATION TO HEMOGLOBIN A1C AMONG BOSNIAN CHILDREN WITH TYPE 1 DIABETES MELLITUS AND THEIR HEALTHY PEERS
Scindeks Assistant Scindeks Assistant — A system for serious journals and those aspiring to become one
PDF

Abstract

Background: Altered level of many hematological parameters have been directly associated with diabetes in adults, while studies on children with type 1 diabetes mellitus are lacking. The aim of this study was to determine hematological indices in diabetic Bosnian children in comparison to healthy controls as well as to correlate their levels to blood glucose and hemoglobin A1c. 

Methods: 100 healthy and 100 children with type 1 diabetes mellituss (age 1-18 years) were included in this study. Complete Blood Count, Hemoglobin A1c and glucose were tested. Results were analysed by IBM SPSS Statistics version 23.

Results: Significant differences (p<0.05) between healthy and diabetic children were found in HbA1c, glucose, Mean Platelet Volume, number of white blood cells and erythrocytes, hematocrit, hemoglobin and MCH values. No gender differences or significant age differences were seen for hemoglobin, hematocrit and MCV, while platelets, MPV and MCH differed by age only in healthy children. When diabetic children were classified according to HbA1c levels, significant differences were seen for erythrocyte count and hematocrit value (p=0.013 and 0.019 respectively). Number of erythrocytes and white blood cells correlated significantly with HbA1c (p=0.037 and 0.027 respectively).

Conclusion: Lower levels of erythrocytes, hematocrit and hemoglobin in diabetic compared to healthy children indicate possible development of anemia, while higher MCV, MCH and MPV values indicate alteration in erythrocyte morphology. Hematological indices could be useful inexpensive tool in diagnosis and follow up of type 1 diabetes in children.

Keywords

Array
DOI: 10.5937/jomb0-25315

References

The published articles will be distributed under the Creative Commons Attribution 4.0 International License (CC BY). It is allowed to copy and redistribute the material in any medium or format, and remix, transform, and build upon it for any purpose, even commercially, as long as appropriate credit is given to the original author(s), a link to the license is provided and it is indicated if changes were made. Users are required to provide full bibliographic description of the original publication (authors, article title, journal title, volume, issue, pages), as well as its DOI code. In electronic publishing, users are also required to link the content with both the original article published in Journal of Medical Biochemistry and the licence used.

Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.

Downloads

Download data is not yet available.